Haupt Pharma AG
Haupt Pharma AG, a leading contract development and manufacturing organisation (CDMO), is headquartered in Germany and operates extensively across Europe. Founded in 1994, the company has established itself as a key player in the pharmaceutical industry, specialising in the development and production of solid dosage forms, sterile products, and complex formulations. With a commitment to quality and innovation, Haupt Pharma AG offers a comprehensive range of services, including formulation development, analytical services, and regulatory support. Their state-of-the-art facilities and adherence to stringent quality standards set them apart in the competitive landscape. Recognised for their expertise and reliability, Haupt Pharma AG has achieved significant milestones, including successful partnerships with major pharmaceutical companies. Their dedication to excellence positions them as a trusted partner in the global healthcare market.
DitchCarbon Score
How does Haupt Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Haupt Pharma AG's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Haupt Pharma AG's reported carbon emissions
Haupt Pharma AG currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data and reduction initiatives, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This includes setting ambitious targets for reducing greenhouse gas emissions and enhancing energy efficiency. Haupt Pharma AG may be expected to align with these industry trends as part of its corporate responsibility and commitment to environmental stewardship.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haupt Pharma AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
